Phase 2 Upper Tract Urothelial Carcinoma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Upper Tract Urothelial Carcinoma
Henry Ford Health System10 enrolled1 locationNCT06948552
Recruiting
Phase 1Phase 2
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Low-grade Upper Tract Urothelial Carcinoma
Ferring Pharmaceuticals20 enrolled7 locationsNCT06668493
Recruiting
Phase 2
Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC
Upper Tract Urothelial Carcinoma
Samsung Medical Center48 enrolled1 locationNCT07225374
Recruiting
Phase 2
Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
Neoadjuvant TherapyPD-1 InhibitorUpper Tract Urothelial Carcinoma+1 more
Tianjin Medical University Second Hospital35 enrolled1 locationNCT07126119
Recruiting
Phase 2
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
CarcinomaUpper Tract Urothelial CarcinomaUTUC
Jinling Hospital, China30 enrolled1 locationNCT05917158